Detalhe da pesquisa
1.
Quantifying hospital-associated costs, and accompanying travel costs and productivity losses, before and after withdrawing tumour necrosis factor-alfa inhibitors in juvenile idiopathic arthritis.
Rheumatology (Oxford)
; 2023 Dec 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38123516